C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/415 (2006.01) A61K 31/4745 (2006.01) C07D 231/14 (2006.01) C07D 471/02 (2006.01)
Patent
CA 2482004
Compounds of Formula III (see formula III) are provided that are amide analogs of SR141716A having unique CB1 receptor selectivity and providing WIN sparing binding characteristics, pharmaceutical compositions containing the compounds and their use in a method of treatment of CB1 receptor related disorders, such as obesity, schizophrenia, memory dysfunction and marijuana abuse.
L'invention concerne des composés qui sont des analogues amides de SR141716A présentant une sélectivité de récepteur unique CB1 et assurent des caractéristiques de liaison économisant les WIN. L'invention traite aussi de compositions pharmaceutiques contenant ces composés et de leur utilisation dans un procédé de traitement des troubles liés au récepteur CB1, comme l'obésité, la schizophrénie, les troubles de la mémoire et l'abus de marijuana.
Francisco Maria Elena Y.
Seltzman Herbert H.
Thomas Brian F.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Research Triangle Institute
LandOfFree
Compounds having unique cb1 receptor binding selectivity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having unique cb1 receptor binding selectivity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having unique cb1 receptor binding selectivity and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505891